Terrence Higgins Trust uses cookies to improve your experience of our websites. For more information or to change the use of cookies, please click here.

Accept and Close

dolutegravir (Tivicay)

Tivicay - Dolutegravir

Generic name: dolutegravir

Brand names: Tivicay

Class: Individual integrase inhibitors (INSTIs)


Common: Nausea, diarrhoea, headache, rash, itching, vomiting, stomach pain or discomfort, insomnia (difficulty sleeping), dizziness, abnormal dreams, fatigue, flatulence, depression, increase in liver enzymes, increase in creatine phosphokinase (enzymes produced in the muscles).

Rare: Allergic reaction, liver inflammation, suicidal thoughts and behaviours.


One 50mg tablet, once a day.

For HIV known to be resistant to integrase inhibitors, or if you are taking dolutegravir with certain other medicines, the dose is 50mg twice a day with food.


Can be taken with or without food.

If you are taking dolutegravir twice a day, you may be advised to take it with food.

*Last review: 25/09/2015 Next review: 25/09/2018

Any questions? Email feedback@tht.org.uk Information included on this website was correct at the time of publication.

Data and image supplied by NAM.

Further information on this drug from NAM